Skip to main content
Signal8

BioELife Corp. (LITH)

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

U.S. LITHIUM CORP logo

U.S. LITHIUM CORP

OTC:LITHHealthcare
$0.0001
CLOSED
Mkt Cap$941
EV-
Float6.92M
O/S9.41M
Inst Own-
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 11, 20260.00000.00000.00000.0000500
Nov 9, 20260.00010.00010.00010.0001150
Oct 12, 20260.00010.00010.00010.0001125
Oct 6, 20260.00010.00010.00010.0001250
Oct 5, 20260.00010.00010.00010.0001327
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Engaged in the cannabinoid industry, BioELife Corp. provides a comprehensive selection of products. Their offerings span a variety of items such as adult gummies and tinctures (both available in combo formulations with chirorub), an intensive relief rub, standard tinctures, additional adult gummies, premium pre-rolled products, and flower.

The company, established in 2006, was formerly known as US Lithium Corp. and underwent a name change to BioELife Corp. in March of 2020.

Its operational base is located in Seal Beach, California.

Key Metrics
Market Cap$941
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 9.41M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateAug 7, 2009
Shares Outstanding9.41M
Authorized Shares
Float6.92M
52-Week Range
$0.0000$0.0002
$0.0001(50th percentile)
Volume
Average Daily Volume325

30d Avg

325

60d Avg

298

90d Avg

305

Earnings
Dividend History
No dividend history available

BioELife Corp. (OTC: LITH) traded at $0.0001 on Nov 16, 2026. 52-week range: $0.0000 to $0.0002. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).